A lentiviral vector-based genetic sensor system for comparative analysis of permeability and activity of vitamin D3 analogues in xenotransplanted human skin

Experimental Dermatology

Volumn 22, Issue 3, 2013, Pages 178-183

  Staunstrup, Nicklas Heine ^a,b   Bak, Rasmus O ^a   Cai, Yujia ^a   Svensson, Lars ^c   Petersen, Thomas K ^c   Rosada, Cecilia ^a   Stenderup, Karin ^a   Bolund, Lars ^a,b   Mikkelsen, Jacob Giehm ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b HuaDa JiYin (BGI)   (China)

^c LEO Pharma ^*  (Denmark)

Author keywords

Drug sensor; Lentiviral vectors; Topical drug delivery; Vitamin D3 analogues; Xenotransplantation model

Indexed keywords

CALCIPOTRIOL; CALCITRIOL; COLECALCIFEROL DERIVATIVE; EB 1213; FIREFLY LUCIFERASE; LENTIVIRUS VECTOR; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BIOLUMINESCENCE; CELL TRANSPORT; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; SKIN; SKIN PERMEABILITY; VIRAL GENE DELIVERY SYSTEM; XENOTRANSPLANTATION;

ADMINISTRATION, TOPICAL; ANIMALS; CELL LINE; CELL MEMBRANE PERMEABILITY; CHOLECALCIFEROL; GENETIC VECTORS; HEK293 CELLS; HUMANS; KERATINOCYTES; LENTIVIRUS; LUCIFERASES; LUMINESCENT MEASUREMENTS; MICE; MICE, SCID; MODELS, ANIMAL; SKIN; SKIN TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84875010299     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12091     Document Type: Article

References (48)

1. Bikle D D. Exp Dermatol 2011: 20: 7-13.
2. DeLuca H F. Am J Clin Nutr 2004: 80: 1689S-1696S.
3. Christakos S, Dhawan P, Liu Y et al. J Cell Biochem 2003: 88: 695-705.
4. Holick M F. N Engl J Med 2007: 357: 266-281.
5. Haussler M R, Jurutka P W, Hsieh J C et al. Bone 1995: 17: 33S-38S.
6. Bettoun D J, Burris T P, Houck K A et al. Mol Endocrinol 2003: 17: 2320-2328.
7. Umesono K, Murakami K K, Thompson C C et al. Cell 1991: 65: 1255-1266.
8. Issa L L, Leong G M, Eisman J A. Inflamm Res 1998: 47: 451-475.
9. Liu S M, Koszewski N, Lupez M et al. Mol Endocrinol 1996: 10: 206-215.
10. Takahashi H, Ibe M, Honma M et al. Arch Dermatol Res 2003: 295: 80-87.
11. Zhang X, Zanello L P. J Bone Miner Res 2008: 23: 1238-1248.
12. Harant H, Andrew P J, Reddy G S et al. Eur J Biochem 1997: 250: 63-71.
13. D'Ambrosio D, Cippitelli M, Cocciolo M G et al. J Clin Invest 1998: 101: 252-262.
14. Eelen G, Verlinden L, van Camp M et al. J Bone Miner Res 2004: 19: 133-146.
15. Brown A J, Slatopolsky E. Mol Aspects Med 2008: 29: 433-452.
16. Masuda S, Jones G. Mol Cancer Ther 2006: 5: 797-808.
17. Albert D M, Kumar A, Strugnell S A et al. Arch Ophthalmol 2004: 122: 1357-1362.
18. Scott L J, Dunn C J, Goa K L. Am J Clin Dermatol 2001: 2: 95-120.
19. Menter A, Korman N J, Elmets C A et al. J Am Acad Dermatol 2011: 65: 137-174.
20. Staunstrup N H, Sharma N, Bak R O et al. BMC Biotechnol 2011: 11: 33.
21. Bak R O, Stenderup K, Rosada C et al. BMC Dermatol 2011: 11: 5.
22. Jakobsen M, Stenderup K, Rosada C et al. Mol Ther 2009: 17: 1743-1753.
23. Baek S C, Lin Q, Robbins P B et al. Hum Gene Ther 2001: 12: 1551-1558.
24. Siprashvili Z, Khavari P A. Mol Ther 2004: 9: 93-100.
25. Primo M N, Bak R O, Mikkelsen J G. Exp Dermatol 2012: 21: 162-170.
26. Moldt B, Staunstrup N H, Jakobsen M et al. BMC Biotechnol 2008: 8: 60.
27. Kragballe K. J Am Acad Dermatol 1992: 27: 1001-1008.
28. Hansen C M, Mathiasen I S, Binderup L. J Investig Dermatol Symp Proc 1996: 1: 44-48.
29. Deroose C M, Reumers V, Gijsbers R et al. Mol Ther 2006: 14: 423-431.
30. Nagpal S, Na S, Rathnachalam R. Endocr Rev 2005: 26: 662-687.
31. Cantorna M T, Hayes C E, DeLuca H F. Proc Natl Acad Sci USA 1996: 93: 7861-7864.
32. Cantorna M T, Munsick C, Bemiss C et al. J Nutr 2000: 130: 2648-2652.
33. Pittas A G, Dawson-Hughes B, Li T et al. Diabetes Care 2006: 29: 650-656.
34. Lee J H, O'Keefe J H, Bell D et al. J Am Coll Cardiol 2008: 52: 1949-1956.
35. Raisanen-Sokolowski A K, Pakkala I S, Samila S P et al. Transplantation 1997: 63: 936-941.
36. White S, Vender R, Thaci D et al. Am J Clin Dermatol 2006: 7: 177-184.
37. Hruby M, Urena P, Mannstadt M et al. Nephrol Dial Transplant 1996: 11: 1781-1786.
38. Bury Y, Ruf D, Hansen C M et al. J Invest Dermatol 2001: 116: 785-792.
39. Solvsten H, Svendsen M L, Fogh K et al. Arch Dermatol Res 1997: 289: 367-372.
40. Gniadecki R. Br J Pharmacol 1997: 120: 1119-1127.
41. Thompson J F, Hayes L S, Lloyd D B. Gene 1991: 103: 171-177.
42. Leclerc G M, Boockfor F R, Faught W J et al. Biotechniques 2000: 29: 590-591, 594-596 598 passim.
43. Hemmingsen C, Staun M, Lewin E et al. Calcif Tissue Int 1996: 59: 371-376.
44. Binderup L. Pharmacol Toxicol 1993: 72: 240-244.
45. Svendsen M L, Daneels G, Geysen J et al. Pharmacol Toxicol 1997: 80: 49-56.
46. Ma Y, Khalifa B, Yee Y K et al. J Clin Invest 2006: 116: 892-904.
47. Zugel U, Steinmeyer A, May E et al. Exp Dermatol 2009: 18: 619-627.
48. Laverny G, Penna G, Uskokovic M et al. J Med Chem 2009: 52: 2204-2213.